Yao L - Search Results

1

Correlation between Serum IL-35 Levels and Bone Loss in Postmenopausal Women with Rheumatoid Arthritis.

Li Y, Yao L, Liu S, JishengWu, Xia L, Shen H, Lu J. Li Y, et al. Among authors: yao l. Mediators Inflamm. 2019 Aug 26;2019:9139145. doi: 10.1155/2019/9139145. eCollection 2019. Mediators Inflamm. 2019. PMID: 31534439 Free PMC article.

2

Serum levels of soluble ST2 and interleukin-33 in patients with dermatomyositis and polymyositis.

Yuan L, Yao L, Zhao L, Xia L, Shen H, Lu J. Yuan L, et al. Among authors: yao l. Clin Exp Rheumatol. 2013 May-Jun;31(3):428-32. Epub 2013 Mar 13. Clin Exp Rheumatol. 2013. PMID: 23485578

3

Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome.

Zhao L, Yao L, Yuan L, Xia L, Shen H, Lu J. Zhao L, et al. Among authors: yao l. Cytokine. 2013 Oct;64(1):22-4. doi: 10.1016/j.cyto.2013.07.006. Epub 2013 Jul 31. Cytokine. 2013. PMID: 23910012

4

Interleukin-35 attenuates collagen-induced arthritis through suppression of vascular endothelial growth factor and its receptors.

Wu S, Li Y, Li Y, Yao L, Lin T, Jiang S, Shen H, Xia L, Lu J. Wu S, et al. Among authors: yao l. Int Immunopharmacol. 2016 May;34:71-77. doi: 10.1016/j.intimp.2016.02.018. Epub 2016 Feb 26. Int Immunopharmacol. 2016. PMID: 26922678

5

Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.

Wu S, Li Y, Yao L, Li Y, Jiang S, Gu W, Shen H, Xia L, Lu J. Wu S, et al. Among authors: yao l. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):223-227. Epub 2017 Aug 28. Clin Exp Rheumatol. 2018. PMID: 28850026

6

Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity.

Li Y, Yao L, Liu S, Wu J, Xia L, Shen H, Lu J. Li Y, et al. Among authors: yao l. J Investig Med. 2019 Mar;67(3):707-710. doi: 10.1136/jim-2018-000814. Epub 2019 Jan 18. J Investig Med. 2019. PMID: 30659089

7

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis.

Zhang H, Li Y, Yuan L, Yao L, Yang J, Xia L, Shen H, Lu J. Zhang H, et al. Among authors: yao l. Front Endocrinol (Lausanne). 2021 Apr 16;12:642676. doi: 10.3389/fendo.2021.642676. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33935967 Free PMC article.

8

Interleukin-35 Regulates Angiogenesis Through P38 Mitogen-Activated Protein Kinase Signaling Pathway in Interleukin-1β-Stimulated SW1353 Cells and Cartilage Bioinformatics Analysis.

Yang J, Yao L, Li Y, Gao R, Huo R, Xia L, Shen H, Lu J. Yang J, et al. Among authors: yao l. J Interferon Cytokine Res. 2021 May;41(5):164-171. doi: 10.1089/jir.2021.0016. J Interferon Cytokine Res. 2021. PMID: 34003680

9

Interleukin-35 inhibits angiogenesis through T helper17/ Interleukin-17 related signaling pathways in IL-1β-stimulated SW1353 cells.

Yang J, Yao L, Li Y, Yuan L, Gao R, Huo R, Zhang H, Xia L, Shen H, Lu J. Yang J, et al. Among authors: yao l. Mol Immunol. 2022 Jul;147:71-80. doi: 10.1016/j.molimm.2022.04.015. Epub 2022 Apr 30. Mol Immunol. 2022. PMID: 35504060

10

IL-35 inhibits adipogenesis via PPARγ-Wnt/β-catenin signaling pathway by targeting Axin2.

Li Y, Yao L, Lu J. Li Y, et al. Among authors: yao l. Int Immunopharmacol. 2023 Sep;122:110615. doi: 10.1016/j.intimp.2023.110615. Epub 2023 Jul 8. Int Immunopharmacol. 2023. PMID: 37429144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,855 results

Search Page

Filters